Pivotal Therapeutics Inc

Ordinary Shares International Reporting
Pink Current Information
Contact Info
  • 81 Zenway Blvd.
  • Unit 10
  • Woodbridge, ONT L4H 0S5
  • Canada

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status International Reporting: Canadian Securities Exchange
Latest Report Jun 30, 2015 Interim Financial Report
Fiscal Year End 12/31
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 8000 - Services-Health Services
Incorporated In: Canada
Year of Inc. 2010
Employees 10 a/o Jul 31, 2015
Company Officers/Contacts
George Jackowski Co-Founder, Chief Scientific Officer
Rachelle MacSweeney Co-Founder, President, COO
Eugenio G. Bortoluzzi Co-Founder, CEO, CFO
Company Directors
John Gebhardt Chairman
Eugenio G. Bortoluzzi
James J. Carey
George Jackowski
Rachelle MacSweeney
Service Providers
Accounting/Auditing Firm
Meyers Norris Penny, LLP
900- 50 Burnhamthorpe Road West
Sussex Centre
Mississauga, ONT, L5B3C2
Securities Counsel
Law Office of Stewart Merkin
444 Brickell Avenue
Suite 300
Rivergate Plaza
Miami, FL, 33131
United States
Investor Relations Firm

Not Available
PVTTF Security Details
Share Structure
Market Value1 $95,794 a/o Sep 21, 2017
Authorized Shares Unlimited a/o Aug 27, 2015
Outstanding Shares 95,794,432 a/o Sep 28, 2015
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 53,453,509 a/o Feb 13, 2012
Par Value Not Available
Transfer Agent(s)
Shareholders of Record Not Available
Non US Stock Exchange Listing
PVO - Canadian Securities Exchange - Qualified
Short Selling Data
Short Interest 3,465 (0%)
Jun 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security